clinical trial · NCT06124404
Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·phase2·completed·n = 36
Mechanically Ventilated PatientsRemimazolam besylateRemimazolam besylateRemimazolam besylate
brief summary
This is a Phase II, dose-escalation clinical trial conducted in mechanically ventilated patients receiving sedation no longer than 24 hours. The efficacy, safety, and pharmacokinetics of remimazolam besylate were evaluated using a randomized, single-blind design.
started
Apr 8, 2022
primary completion
Feb 28, 2023
completion
Feb 28, 2023
last updated
Mar 19, 2026
official title
A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Injection for Sedation in ICU Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol